Mitochondria-targeted nanomedicines for cardiovascular applications.

Published in: Nanomedicine (London, England) (2023)

Tweetable abstract Mitochondria are increasingly a target for drug delivery in cardiovascular diseases. This editorial describes how a nanomedicine approach may improve drug potency and efficacy in a safe and controlled manner.

Keyphrases

cancer therapy
drug delivery
cardiovascular disease
cell death
endoplasmic reticulum
reactive oxygen species
emergency department
drug release
cardiovascular risk factors
metabolic syndrome
adverse drug
drug induced
electronic health record